No­vavax CFO Greg Covi­no makes a quick ex­it as lead­er­ship carousel keeps turn­ing; Kite ex­ecs fly away to a cell ther­a­py up­start team­ing up with Lyell

→ If it seems like Covid-19 vac­cine brides­maid No­vavax is shut­tling staffers in and out, you’re not alone. This week, Greg Covi­no an­nounced he’s leav­ing the biotech af­ter hold­ing the CFO job for a blink-and-you-miss-it tenure. An ad­vi­so­ry role with­in the com­pa­ny awaits for Covi­no, who came to No­vavax just five months ago from Bris­tol My­ers Squibb, while CCO and CBO John Trizzi­no jug­gles even more ex­ec­u­tive re­spon­si­bil­i­ty by tak­ing on the in­ter­im CFO ti­tle.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA